Ginkgo & Brahmi

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

Ginkgo biloba, Quantity: 60 mg (Equivalent: Ginkgo biloba, Qty 3 g); Bacopa monnieri, Quantity: 150 mg (Equivalent: bacosides calculated as bacoside A (of Bacopa monnieri), Qty 67.5 mg; Equivalent: Bacopa monnieri, Qty 3000 mg)

Disponible depuis:

Digital Services Australia II Pty Ltd

forme pharmaceutique:

Capsule, hard

Composition:

Excipient Ingredients: purified water; colloidal anhydrous silica; Oryza sativa; hypromellose; Acacia; Sunflower Oil

Mode d'administration:

Oral

indications thérapeutiques:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Maintain/support healthy eye function ; Maintain/support eye health ; Enhance/promote body adaptation to stress ; Decrease/reduce/relieve nervous tension/unrest ; Decrease/reduce/relieve symptoms of mild anxiety ; Maintain/support mental concentration/focus/clarity ; Maintain/support cognitive function/mental function ; Maintain/support learning and information processing ; Enhance/improve/promote/increase mental alertness/wakefulness ; Maintain/support memory/mental recall ; Maintain/support brain function ; Traditionally used in Chinese medicine to Nourish the brain ; Traditionally used in Chinese medicine to Maintain/support brain health ; Traditionally used in Ayurvedic medicine to Brain tonic/Enhance brain health ; Maintain/support nervous system health

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Listed

Date de l'autorisation:

2021-10-15